Results 151 to 160 of about 85,886 (213)

An experimental medicine protocol for exploring the haemodynamic effects of dual agonism at the glucagon‐like peptide‐1 and glucagon receptor in healthy subjects

British Journal of Clinical Pharmacology, Volume 92, Issue 2, Page 579-588, February 2026.
Aims Glucagon‐like peptide‐1 (GLP‐1) and glucagon dual receptor agonists are in clinical development for a range of metabolic conditions, including type 2 diabetes and obesity. The cardiovascular actions at these receptors are well studied, but less is known about their combination.
James Goodman, Victoria E. Parker, Carmel M. McEniery, Giovanni Di Stefano, Annette Hubsch, Evangelia Vamvaka, Jo Helmy, Fotini Kaloyirou, Navazh Jalaludeen, Peter Barker, Lutz Jermutus, Joseph Cheriyan, Philip Ambery, Ian B. Wilkinson   +13 more
wiley   +1 more source

An Exploratory Single-Arm Clinical Trial on Eucommia Ulmoides Leaf Extract Effects on Blood Pressure, Oxidative Stress, and Atrial Natriuretic Peptide (ANP) in Individuals With and Without Chronic Kidney Disease. [PDF]

Int J Nephrol
Satonaka H, Yokoyama S, Ishimitsu A, Takahashi C, Rai T, Nagata D, Ishimitsu T, Tojo A.   +7 more
europepmc   +1 more source

Heat Therapy: Targeting Health, Disease, and Disability

Comprehensive Physiology, Volume 16, Issue 1, February 2026.
The predominance of evidence suggests heat therapy has an impact on all aspects of health and performance, but the drivers of that improvement, the extent to which they are improved, and the specific populations in which improvements manifest are far from completely understood.
Rauchelle E. Richey, Robert D. Hyldahl, Brendan W. Kaiser, Paige C. Geiger, John R. Halliwill, Christopher T. Minson   +5 more
wiley   +1 more source

High Serum Adrenomedullin and Mid-Regional Pro-Atrial Natriuretic Peptide Concentrations in Early Pregnancy Predict the Development of Gestational Hypertension. [PDF]

Diagnostics (Basel)
Jagodzinska A, Wsol A, Gondek A, Cudnoch-Jedrzejewska A.   +3 more
europepmc   +1 more source

Degradation and clearance of atrial natriuretic factors [PDF]

, 1990
Adnot, Almeida, Anand-Srivastava, Anand-Srivastava, Anderson, Ando, Arendt, Arendt, Ballermann, Ballermann, Bates, Bertrand, Bianchi, Bianchi, Cachofeiro, Cantin, Cantin, Chartier, Chinkers, Cody, Crozier, De Bold, De Lean, Drexler, Espiner, Fethiere, Fulcher, Gerbes, Gerbes, Gerbes, Gines, Gros, Gutkowska, Hasegawa, Henriksen, Hinko, Hollister, Inagami, Kenny, Koehn, Koepke, Kollenda, Koseki, Krieter, Kurosawa, Lafferty, Laffi, Lang, Lang, Laragh, Leitman, Lieorens, Luft, Maack, Mantyh, Marumo, Masuda, Matsas, Matsas, Matsas, Misono, Murthy, Nakao, Needleman, Northridge, Olins, Olins, Olins, Pandey, Porter, Predel, Raine, Richards, Riegger, Saito, Scarborough, Schafferhans, Schiebinger, Schutten, Schwartz, Seymour, Shima, Sonnenberg, Stephenson, Stewart, Sudhir, Sugiyama, Sybertz, Sybertz, Takayanagi, Tamburini, Tang, Thibault, Trapani, Trapani, Trippodo, Vierhapper, Vollmar, Vollmar, Vollmar, Webb, Woods, Yukimura   +102 more
core   +1 more source

Skeletal Muscle Mass Modifies the Prognostic Impact of LDL Cholesterol in Chronic Heart Failure

Journal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 1, February 2026.
ABSTRACT Background Dyslipidaemia is among the major risk factors for atherosclerotic cardiovascular disease. Paradoxically, higher cholesterol levels are associated with better survival in heart failure (HF) of any aetiology. Because cholesterol is an integral component of skeletal muscle structure, one possible explanation involves the interplay ...
Ryosuke Sato, Tania Garfias‐Veitl, Guglielmo Fibbi, Mirela Vatic, Wolfram Doehner, Stefan D. Anker, Stephan von Haehling   +6 more
wiley   +1 more source

Loss of atrial natriuretic peptide signaling causes insulin resistance, mitochondrial dysfunction, and low endurance capacity. [PDF]

Sci Adv
Carper D, Lac M, Coue M, Labour A, Märtens A, Banda JAA, Mazeyrie L, Mechta M, Ingerslev LR, Elhadad M, Petit JV, Maslo C, Monbrun L, Del Carmine P, Sainte-Marie Y, Bourlier V, Laurens C, Mithieux G, Joanisse DR, Coudray C, Feillet-Coudray C, Montastier E, Viguerie N, Tavernier G, Waldenberger M, Peters A, Wang-Sattler R, Adamski J, Suhre K, Gieger C, Kastenmüller G, Illig T, Lichtinghagen R, Seissler J, Mounier R, Hiller K, Jordan J, Barrès R, Kuhn M, Pesta D, Moro C.   +40 more
europepmc   +1 more source

Current Trends in Duchenne Muscular Dystrophy Research and Therapy: 3D Cardiac Modelling

Journal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 1, February 2026.
ABSTRACT Duchenne muscular dystrophy (DMD), caused by dystrophin deficiency, presents a multifaceted challenge that affects both skeletal muscle function and cardiomyocyte homeostasis, causing progressive degeneration and life‐threatening cardiac complications by adolescence.
Marta Przymuszała, Marta Białobrzeska, Józef Dulak, Urszula Florczyk‐Soluch   +3 more
wiley   +1 more source

Plasma Atrial Natriuretic Peptide Predicts Oxidized Low-Density Lipoprotein Levels in Type 2 Diabetes Mellitus Patients Independent of Circulating Adipokine and Cytokine. [PDF]

Int J Mol Sci
Bakillah A, Al Subaiee M, Soliman AF, Obeid KK, Bashir SF, Al Hussaini A, Al Arab M, Al Otaibi A, Mubarak SAS, Al Qarni AA.   +9 more
europepmc   +1 more source

Temporal Variability and Influence of Measurement Conditions of AI‐Based Atrial Fibrillation Risk Estimation

Journal of Arrhythmia, Volume 42, Issue 1, February 2026.
The atrial fibrillation (AF) risk estimated by artificial intelligence‐based program installed in electrocardiography (ECG) machine exhibited temporal variability. Reproducibility within one level of error was 100% for the same ECG, 95% for reproducibility within 4 min interval, and 87% for reproducibility over 15 min interval.
Satomi Hamada, Miki Amemiya, Mie Ochida, Susumu Tao, Iwanari Kawamura, Tetsuo Sasano   +5 more
wiley   +1 more source